Literature DB >> 25030909

The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

E C Serefoglu1, L Trost2, S C Sikka3, W J G Hellstrom3.   

Abstract

Although the association between Peyronie's disease (PD) and erectile dysfunction (ED) is well established, limited data are available correlating penile curvature and penile hemodynamic parameters. We sought to examine this association in a cohort of PD men undergoing penile duplex Doppler ultrasound (PDDU). PD patients were retrospectively evaluated to correlate the extent and direction of penile curvature with measured vascular parameters. Demographic variables, disease characteristics and PDDU parameters were tabulated and statistically compared based on extent (≤ 45° and >45°) and direction (dorsal, ventral, lateral, ventrolateral, dorsolateral) of curvature. A total of 220 PD patients (mean age of 55.0 ± 9.2 years) underwent PDDU at one institution from January 2008 to December 2010. Overall, 69.5% of patients were found to have vasculogenic ED (arterial insufficiency (AI): 10%; veno-occlusive dysfunction (VOD): 43.2%; AI + VOD: 16.4%). Mean curvature was similar among all PDDU groups (AI: 41.7 ± 5.2°; VOD: 41.3 ± 2.5°; AI+VOD: 37 ± 4.1°; no-ED: 37.3 ± 3°; P > 0.85). No significant differences were noted in the presence or type of ED among various directions of curvature (P = 0.34) or when curvatures were stratified by ≤ 45° and >45°. The direction and extent of penile curvature are not associated with altered rates of vasculogenic ED on PDDU in PD patients.

Entities:  

Mesh:

Year:  2014        PMID: 25030909     DOI: 10.1038/ijir.2014.25

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  33 in total

1.  Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?

Authors:  Benjamin N Breyer; Alan W Shindel; Yun-Ching Huang; Michael L Eisenberg; Dana A Weiss; Tom F Lue; James F Smith
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

Review 2.  Mechanisms of penile fibrosis.

Authors:  Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

Review 3.  Understanding the course of Peyronie's disease.

Authors:  G Garaffa; L W Trost; E C Serefoglu; D Ralph; W J G Hellstrom
Journal:  Int J Clin Pract       Date:  2013-08       Impact factor: 2.503

4.  Colour Doppler and duplex ultrasound assessment of Peyronie's disease in impotent men.

Authors:  Z Amin; U Patel; E P Friedman; J A Vale; R Kirby; W R Lees
Journal:  Br J Radiol       Date:  1993-05       Impact factor: 3.039

5.  The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984.

Authors:  M B Lindsay; D M Schain; P Grambsch; R C Benson; C M Beard; L T Kurland
Journal:  J Urol       Date:  1991-10       Impact factor: 7.450

6.  Penile sonographic and clinical characteristics in men with Peyronie's disease.

Authors:  James F Smith; William O Brant; Vincent Fradet; Alan W Shindel; Eric Vittinghoff; Thomas Chi; Yun-Ching Huang; Cole B Davis; Simon Conti; Tom F Lue
Journal:  J Sex Med       Date:  2009-08-28       Impact factor: 3.802

7.  Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease.

Authors:  Mustafa F Usta; Trinity J Bivalacqua; George W Jabren; Leann Myers; Jose Sanabria; Suresh C Sikka; Wayne J G Hellstrom
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

Review 8.  Medical management of Peyronie's disease.

Authors:  Wayne J G Hellstrom
Journal:  J Androl       Date:  2008-10-30

Review 9.  Peyronie's disease: a critical appraisal of current diagnosis and treatment.

Authors:  J F Smith; T J Walsh; T F Lue
Journal:  Int J Impot Res       Date:  2008-07-24       Impact factor: 2.896

10.  A retrospective review of 307 men with Peyronie's disease.

Authors:  Ates Kadioglu; Ahmet Tefekli; Bulent Erol; Tayfun Oktar; Murat Tunc; Sedat Tellaloglu
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.